Normunity
PrivateLast Round
Series B
Jan 13, 2025
Est. Valuation
$500M
Total Funding Raised
$140M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Normunity is a biotechnology company that develops precision immuno-oncology therapies designed to restore the immune system's natural ability to identify and eliminate cancer cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Normunity Comparables
Compare Normunity with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Marengo Therapeutics | 84% | |
| Merck | 81% | |
| EvolveImmune | 80% |
Normunity Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 13, 2025 | ||||
| Series A | Oct 25, 2022 |
Key People
Founding team and executive leadership
Normunity Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Enavate Sciences | Series B |
| Connecticut Innovations | Series B |
| Taiho Ventures | Series B, Series A |
| Osage University Partners | Series B, Series A |
| Canaan Partners | Series B, Series A |
| Pfizer Ventures | Series B |
| Sanofi Ventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 36% MoM, reaching 2K.
- Jul 26, 2026
Monthly visitors grew 40% MoM, from 1K to 1.5K.
Normunity Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Normunity's valuation, stock price, and market status.
Is Normunity a public or private company?
Normunity is a private company.
What is the current stock price of Normunity?
Normunity is a private company with no public stock price. No recent secondary market data is available.
How much is Normunity worth (valuation)?
Normunity's valuation is estimated at $500.0M based on funding round data.
Can I buy Normunity stock?
Normunity shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Normunity's last funding round?
Normunity's most recent funding round was Series B on January 13, 2025.
Who are the main investors in Normunity?
Key investors in Normunity include Enavate Sciences, Samsara BioCapital.
Will Normunity IPO soon?
No public IPO plans have been announced for Normunity.
How can I track Normunity secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Normunity's secondary market activity and sign up for updates.